Gabelli Securities »

Avadel Pharmaceuticals shares owned by Gabelli Securities

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4M 298k 21.55

More positions owned by Gabelli Securities

Dayforce Equity
Frontier Communications Pare Equity
Chart Industries Equity (GTLS)
Electronic Arts Equity (EA)
Exact Sciences Corp Equity (EXAS)
Avidity Biosciences Equity (RNA)
Cidara Therapeutics Equity (CDTX)
Hologic Equity (HOLX)
Txnm Energy Equity (TXNM)
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Cyberark Software Ltd/israel Equity (CYBR)
Sealed Air Corp Equity (SEE)
Confluent Inc-class A Equity (CFLT)
Gdl Fund Exchange Traded (GDL)
Norfolk Southern Corp Equity (NSC)

View all positions for Gabelli Securities

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Jeffrey L. Gendell
Vanguard Group
Vivo Capital
State Street Corporation
Geode Capital Management
Highbridge Capital Management
Susquehanna International
Wealth Effects
Citadel Advisors
Kennedy Capital Management
Water Island Capital
Krensavage Asset Management
Northern Trust

View all funds holding Avadel Pharmaceuticals